Tenax Therapeutics (TENX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 01-2005 | 12-2004 | 10-2004 | 09-2004 | 07-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,960 | -1,070 | -1,070 | -470 | -470 |
| Depreciation Amortization | 180 | 120 | 120 | 20 | 20 |
| Other Working Capital | 80 | 220 | 220 | 120 | 120 |
| Other Operating Activity | 310 | 10 | 10 | 30 | 30 |
| Operating Cash Flow | $-1,390 | $-720 | $-720 | $-300 | $-300 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -70 | -60 | -60 | -60 | -60 |
| Other Investing Activity | -30 | -20 | -20 | -10 | -10 |
| Investing Cash Flow | $-100 | $-80 | $-80 | $-70 | $-70 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 2,240 | 610 | 610 | 610 | 610 |
| Financing Cash Flow | $2,240 | $610 | $610 | $610 | $610 |
| Beginning Cash Position | 300 | 300 | 300 | 300 | 300 |
| End Cash Position | 1,050 | 110 | 110 | 530 | 530 |
| Net Cash Flow | $740 | $-190 | $-190 | $230 | $230 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,390 | -720 | -720 | -300 | -300 |
| Free Cash Flow | -1,390 | -720 | -720 | -300 | -300 |